Well discuss these in more detail in below sections
Ada Deranas Ukussa today (04 June) helped uncover another skin-whitening racket in Rajagiriya involving the administration of Glutathione, a drug banned in Sri Lanka
Semaglutide belongs to a group of medications known as GLP-1 receptor agonists
While we lack definitive RCT data, there is a strong physiological rationale and emerging real-world experience suggesting benefits from tapering doses (e.g., 15 12.5 10 2.5 mg) before stopping: Allows neurohormonal pathways to recalibrate gradually rather than abruptly Provides a window to stabilize lifestyle adjustments at each step May help identify a lowest effective maintenance dose that sustains satiety signals Reduces the shock of withdrawal, lowering the risk of rapid rebound Key takeaway: The narrative that all patients regain weight after GLP-1/GIP therapy overlooks an important nuance: regain has been observed when treatment is stopped suddenly at high doses
Labs tell the story
Stepwise linear regression analysis found that the variations in initial BUN/Creatinine ratio could be partially predicted by urinary metal excretion at baseline and after the 9 th dose of Phase 1, with an adjusted R 2 = 0.35, p = 0.0001, with the most significant factors being baseline Sn (p = 0.003), baseline W (p = 0.02), and 9 th dose Sb (p = 0.05)